Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gu Ben Hua Yu Fang + Secukinumab for Severe Plaque Psoriasis
NCT04414605Phase 1Unknown
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Gu Ben Hua Yu Formula in plaque psoriasis, sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Median time to relapse at 1 year. Status: unknown.
02
Drugs
Gu Ben Hua Yu Formula
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04414605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04414605.